Stephanie Kern lost her husband to PSP, a disease so rare that only 5 out of every 100,000 people get it. She shares her ...

Progressive supranuclear palsy (PSP) is a rare neurodegenerative condition that is a form of atypical parkinsonism, meaning that it shares some features with Parkinson's disease. These include ...

Although overlap exists, PSP diagnostic criteria are very specific in diagnosing this disease, whereas CBD criteria need to be refined and validated. The premortem diagnosis of CBD is very ...

Progressive supranuclear palsy (PSP) is a severe and rapidly progressing neurodegenerative disease that affects both motor and cognitive functions. Often misdiagnosed or underdiagnosed due to a ...

Borroni et al. have previously demonstrated that both extended (55 kDa) and truncated (33 kDa) forms of tau protein are present in the cerebrospinal fluid (CSF) and cerebral cortex of patients ...

PSP-001 is under clinical development by Prosit Sole Biotechnology (Beijing) and currently in Phase I for Norovirus Infections.

Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Progressive Supranuclear Palsy .

MSA is divided into MSA-C (cerebellar type) which has more symptoms of ataxia (incoordination) and MSA-P (parkinsonian type) which has more parkinsonian symptoms but is relatively unresponsive to the ...